Assessing Knowledge and Perceptions of Alzheimer's Disease Among Employees of a Pharmaceutical Company in Spain: A Comparison Between Caregivers and Non-Caregivers.
Alzheimer’s disease
caregivers
dementia
knowledge
pharmaceutical company
Journal
Patient preference and adherence
ISSN: 1177-889X
Titre abrégé: Patient Prefer Adherence
Pays: New Zealand
ID NLM: 101475748
Informations de publication
Date de publication:
2020
2020
Historique:
received:
18
09
2020
accepted:
12
11
2020
entrez:
9
12
2020
pubmed:
10
12
2020
medline:
10
12
2020
Statut:
epublish
Résumé
Raising knowledge about Alzheimer's disease (AD) may help in identifying the disorder, seeking earlier appropriate healthcare, and decreasing its stigma. The aim of this study was to determine the knowledge and perceptions towards people with AD among employees of a pharmaceutical company in Spain. A non-interventional, cross-sectional study was conducted among 447 employees. Participants answered demographic questions and completed the Alzheimer's Disease Knowledge Scale (ADKS). Caregivers also answered questions related to their personal experience with patients with AD and completed the Satisfaction with Life Scale (SWLS), the Revised Memory and Behavior Problems Checklist (RMBPC), and the Beck Depression Inventory-Fast Screen (BDI-FS). Participants were mostly between 30 and 50 years old (63%), female (65.3%), and had bachelor or master degrees (82.7%). Forty-two (9.4%) of participants were caregivers, mainly of moderate to severe dementia subjects. Overall knowledge about AD was moderate (mean ADKS score = 21.2 ± 2.8 [70.6% of correct answers]). Risk factors and caregiving were the domains with lowest scores (correct answers: 58.58% and 63%, respectively). Mean total ADKS score was significantly higher in participants caring for people with AD compared with non-caregivers (22.1 ± 2.9 and 21.0 ± 2.8; p=0.02, respectively). There was no statistically significant association between total ADKS score and age, sex, educational level, or relative's AD severity. Most caregivers were satisfied with life (mean SWLS score = 26.8 ± 5.6) showing a low impact from behavioral problems (mean RMBPC reaction score = 26.81 ± 20.2). Six of them (14.3%) were scored as depressed. There is a continuing need to improve understanding of AD to fill the gaps in knowledge of the disease, even in a population working in healthcare sector with a high educational level.
Sections du résumé
BACKGROUND
BACKGROUND
Raising knowledge about Alzheimer's disease (AD) may help in identifying the disorder, seeking earlier appropriate healthcare, and decreasing its stigma. The aim of this study was to determine the knowledge and perceptions towards people with AD among employees of a pharmaceutical company in Spain.
METHODS
METHODS
A non-interventional, cross-sectional study was conducted among 447 employees. Participants answered demographic questions and completed the Alzheimer's Disease Knowledge Scale (ADKS). Caregivers also answered questions related to their personal experience with patients with AD and completed the Satisfaction with Life Scale (SWLS), the Revised Memory and Behavior Problems Checklist (RMBPC), and the Beck Depression Inventory-Fast Screen (BDI-FS).
RESULTS
RESULTS
Participants were mostly between 30 and 50 years old (63%), female (65.3%), and had bachelor or master degrees (82.7%). Forty-two (9.4%) of participants were caregivers, mainly of moderate to severe dementia subjects. Overall knowledge about AD was moderate (mean ADKS score = 21.2 ± 2.8 [70.6% of correct answers]). Risk factors and caregiving were the domains with lowest scores (correct answers: 58.58% and 63%, respectively). Mean total ADKS score was significantly higher in participants caring for people with AD compared with non-caregivers (22.1 ± 2.9 and 21.0 ± 2.8; p=0.02, respectively). There was no statistically significant association between total ADKS score and age, sex, educational level, or relative's AD severity. Most caregivers were satisfied with life (mean SWLS score = 26.8 ± 5.6) showing a low impact from behavioral problems (mean RMBPC reaction score = 26.81 ± 20.2). Six of them (14.3%) were scored as depressed.
CONCLUSION
CONCLUSIONS
There is a continuing need to improve understanding of AD to fill the gaps in knowledge of the disease, even in a population working in healthcare sector with a high educational level.
Identifiants
pubmed: 33293798
doi: 10.2147/PPA.S282147
pii: 282147
pmc: PMC7718989
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2357-2364Informations de copyright
© 2020 Garcia-Ribas et al.
Déclaration de conflit d'intérêts
EG-A and JM are employees of Roche Farma Spain. AM is an employee of Hoffmann-La Roche Limited, Canada. The authors report no other conflicts of interest in this work.
Références
Aging Ment Health. 2021 May;25(5):787-796
pubmed: 32048522
Clin Interv Aging. 2019 Jan 18;14:179-193
pubmed: 30697042
Lancet Neurol. 2019 Jan;18(1):88-106
pubmed: 30497964
J Neurol Neurosurg Psychiatry. 2020 Nov;91(11):1201-1209
pubmed: 32690803
BMC Geriatr. 2020 Mar 12;20(1):99
pubmed: 32164544
Gerontologist. 2009 Apr;49(2):236-47
pubmed: 19363018
Alzheimers Dement. 2017 Jan;13(1):1-7
pubmed: 27583652
Disabil Rehabil. 2020 Jul 20;:1-10
pubmed: 32687722
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
J Occup Health Psychol. 2017 Jul;22(3):259-272
pubmed: 28150990
Int J Alzheimers Dis. 2012;2012:903645
pubmed: 22997601
Australas J Ageing. 2017 Mar;36(1):38-45
pubmed: 26970426
BMC Public Health. 2014 Jun 28;14:661
pubmed: 24972448
JBI Evid Synth. 2020 Apr;18(4):647-703
pubmed: 32813338
Ageing Res Rev. 2012 Jan;11(1):67-77
pubmed: 21983429
Int Psychogeriatr. 2020 Jan;32(1):35-52
pubmed: 30967164
Front Pharmacol. 2019 Aug 14;10:860
pubmed: 31474852
Am J Alzheimers Dis Other Demen. 2011 Mar;26(2):121-6
pubmed: 21233137
Alzheimer Dis Assoc Disord. 2015 Jul-Sep;29(3):255-75
pubmed: 26207322
Adv Neurobiol. 2017;15:31-53
pubmed: 28674977
Psychol Aging. 1992 Dec;7(4):622-31
pubmed: 1466831
Arq Neuropsiquiatr. 2018 Nov;76(11):775-782
pubmed: 30570022
Lancet. 2017 Dec 16;390(10113):2673-2734
pubmed: 28735855
Neurologia (Engl Ed). 2021 Jul-Aug;36(6):426-432
pubmed: 34238525
Front Psychol. 2020 Feb 21;11:246
pubmed: 32153465
Arch Gerontol Geriatr. 2021 Jan - Feb;92:104246
pubmed: 32980573
PLoS One. 2018 Apr 19;13(4):e0196085
pubmed: 29672559